The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Countouriotis Athena since year 2005.
The trader's CIK number is 1571469.
At the time of this reporting, Countouriotis Athena is the SVP and Chief Medical Officer of Halozyme Therapeutics Inc .
(stock ticker symbol HTI).
See this page for all insider trading activities at Halozyme Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-02-03||HALO||Halozyme Therapeutics Inc||Option Ex||18,496||.00||0|
|2017-01-05||HALO||Halozyme Therapeutics Inc||Option Ex||7,500||.00||0|
|2016-06-30||HALO||Halozyme Therapeutics Inc||Option Ex||6,450||.00||0|
|2016-01-05||HALO||Halozyme Therapeutics Inc||Option Ex||7,500||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Countouriotis Athena (SVP and Chief Medical Officer of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.